Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.

被引:42
|
作者
Takei H. [1 ]
Suemasu K. [1 ]
Kurosumi M. [1 ]
Horii Y. [1 ]
Yoshida T. [1 ]
Ninomiya J. [1 ]
Yoshida M. [1 ]
Hagiwara Y. [1 ]
Kamimura M. [1 ]
Hayashi Y. [1 ]
Inoue K. [1 ]
Tabei T. [1 ]
机构
[1] Division of Breast Surgery, Saitama Cancer Center, Saitama
关键词
Sentinel lymph node biopsy; Axillary lymph node dissection; Regional nodal recurrence; Risk factor; Breast cancer;
D O I
10.2325/jbcs.14.16
中图分类号
学科分类号
摘要
BACKGROUND: A regional nodal recurrence is a major concern after a sentinel lymph node biopsy (SLNB) alone in patients with breast cancer. In this study we investigated patterns and risk factors of regional nodal recurrence after SLNB alone. PATIENTS AND METHODS: Between January 1999 and March 2005, a series of 1,704 consecutive breast cancer cases in 1,670 patients (34 bilateral breast cancer cases) with clinically negative nodes or suspicious nodes for metastasis who underwent SLNB at a single institute (Saitama Cancer Center) were studied. All 1,704 cases were classified based upon presence or absence of a metastatic lymph node, treated with or without axillary lymph node dissection (ALND). The site of first recurrence was classified as local, regional node, or distant. The regional node recurrences were subclassified as axillary, interpectoral, infraclavicular, supraclavicular, or parasternal. RESULTS: After a median follow-up period of 34 months (range, 2-83 months), first recurrence occurred in local sites in 32 (1.9%) cases, regional nodes in 26 (1.5%) cases, and distant sites in 61 (3.6%) cases. In 1,062 cases with negative nodes treated without ALND and 459 cases with positive nodes treated with ALND, 11 (1.0%) and 15 (3.3%) recurred in regional nodes, respectively, and 4 (0.4%) and 2 (0.6%) recurred in axillary nodes, respectively. Of 822 cases of invasive breast cancer with negative nodes treated with SLNB alone, 10 (1.4%) recurred in regional nodes, and 4 (0.5%) recurred in axillary nodes. In the 10 patients with regional nodal failure, all of the tumors were negative for estrogen receptor (ER) and/or progesterone receptor (PR) and were nuclear grade (NG) 3. CONCLUSIONS: The axillary recurrence rate was low in patients treated with SLNB alone. Omitting ALND is concluded to be safe after adequate SLNB. Risk factors for regional nodal failure after SLNB alone are negative hormone receptor status and high NG.
引用
收藏
页码:16 / 24
页数:8
相关论文
共 50 条
  • [1] Investigation for axillary lymph node alone recurrence after sentinel lymph node biopsy without axillary lymph node dissection for breast cancer
    Kurihara, T.
    Takayama, S.
    Ogisawa, K.
    Shiino, S.
    Jimbo, K.
    Asaga, S.
    Kinoshita, T.
    [J]. BREAST, 2017, 32 : S116 - S117
  • [2] Axillary lymph node dissection in breast cancer patients after sentinel node biopsy
    Jessing, Christina
    Langhans, Linnea
    Jensen, Maj-Britt
    Talman, Maj-Lis
    Tvedskov, Tove Filtenborg
    Kroman, Niels
    [J]. ACTA ONCOLOGICA, 2018, 57 (01) : 166 - 169
  • [3] Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
    Giuliano, Armando E.
    McCall, Linda
    Beitsch, Peter
    Whitworth, Pat W.
    Blumencranz, Peter
    Leitch, A. Marilyn
    Saha, Sukamal
    Hunt, Kelly K.
    Morrow, Monica
    Ballman, Karla
    [J]. ANNALS OF SURGERY, 2010, 252 (03) : 426 - 433
  • [4] Sentinel lymph node biopsy alone without axillary lymph node dissection - follow up of sentinel lymph node negative breast cancer patients
    Reitsamer, R
    Peintinger, F
    Prokop, E
    Menzel, C
    Cimpoca, W
    Rettenbacher, L
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (03): : 221 - 223
  • [5] Sentinel lymph node biopsy alone without axillary lymph node dissection - Follow up of sentinel lymph node negative breast cancer patients
    Reitsamer, R
    Peintinger, F
    Prokop, E
    Rettenbacher, L
    Menzel, C
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S60 - S60
  • [6] Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients
    Zavagno, G
    Carcoforo, P
    Franchini, Z
    Renier, M
    Barutta, L
    De Salvo, GL
    Maravegias, K
    Capitanio, G
    Nitti, D
    Lise, M
    [J]. EJSO, 2005, 31 (07): : 715 - 720
  • [7] Axillary Recurrence after Sentinel Lymph Node Biopsy for Breast Cancer
    Dauphine, Christine
    Nemtsev, Denis
    Rosing, David
    Vargas, Hernan I.
    [J]. AMERICAN SURGEON, 2010, 76 (10) : 1127 - 1129
  • [8] Axillary recurrence after sentinel lymph node biopsy for breast cancer
    Tamaki, Y.
    Tanji, Y.
    Imazato, M.
    Kim, S. J.
    Miyosyi, Y.
    Taguchi, T.
    Ueda, S.
    Ikeda, N.
    Yanagisawa, T.
    Okishiro, K.
    Noguchi, S.
    [J]. Proceedings of the XIV World Congress on Breast Diseases, 2006, : 167 - 170
  • [9] Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
    Sarri, Almir Jose
    Dias, Rogerio
    Laurienzo, Carla Elaine
    Pereira Goncalves, Monica Carboni
    Dias, Daniel Spadoto
    Moriguchi, Sonia Marta
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 1451 - 1457
  • [10] Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients
    Noguchi, M
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2001, 76 (02) : 144 - 156